GIM
Greylin Investment Management Portfolio holdings
AUM
$598M
This Quarter Return
+6.77%
1 Year Return
+18.59%
3 Year Return
+52.1%
5 Year Return
+133.55%
10 Year Return
+215.01%
AUM
$578M
AUM Growth
+$578M
(+3.9%)
Cap. Flow
-$3.54M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
71.9%
Holding
76
New
5
Increased
14
Reduced
44
Closed
1
Top Buys
| 1 |
Pfizer
PFE
|
$4.47M |
| 2 |
Occidental Petroleum Corporation Warrants to Purchase Common Stock
OXY.WS
|
$2.52M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$2.29M |
| 4 |
Organon & Co
OGN
|
$630K |
| 5 |
British American Tobacco
BTI
|
$571K |
Top Sells
| 1 |
Alibaba
BABA
|
$3.66M |
| 2 |
Gilead Sciences
GILD
|
$1.91M |
| 3 |
Viatris
VTRS
|
$1.51M |
| 4 |
Amgen
AMGN
|
$1.16M |
| 5 |
Cardinal Health
CAH
|
$1.13M |
Sector Composition
| 1 | Financials | 41.39% |
| 2 | Technology | 16.55% |
| 3 | Energy | 14.38% |
| 4 | Healthcare | 13.57% |
| 5 | Consumer Staples | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.09T
| $205M | 35.48% | 575,250 -1,213 | -0.2% | -$433K |
|
2
Exxon Mobil
XOM
$487B
| $52.5M | 9.08% | 525,249 -11,136 | -2% | -$1.11M |
|
3
Intel
INTC
$107B
| $51.6M | 8.92% | 1,026,333 -8,276 | -0.8% | -$416K |
|
4
Qualcomm
QCOM
$173B
| $26.3M | 4.55% | 181,786 -2,316 | -1% | -$335K |
|
|
5
Occidental Petroleum Corporation Warrants to Purchase Common Stock
OXY.WS
$24B
| $25M | 4.32% | 641,854 +64,812 | +11% | +$2.52M |
|
6
Johnson & Johnson
JNJ
$427B
| $12M | 2.08% | 76,841 -1,231 | -2% | -$193K |
|
|
7
Organon & Co
OGN
$2.45B
| $11.6M | 2% | 803,097 +43,706 | +6% | +$630K |
|
|
WBA
8
DELISTED
Walgreens Boots Alliance
WBA
| $11.1M | 1.92% | 425,226 +87,660 | +26% | +$2.29M |
|
9
Ally Financial
ALLY
$12.6B
| $10.9M | 1.89% | 312,303 -11,068 | -3% | -$386K |
|
10
ConocoPhillips
COP
$124B
| $9.63M | 1.66% | 82,955 -1,025 | -1% | -$119K |
|
|
11
Amgen
AMGN
$155B
| $8.8M | 1.52% | 30,567 -4,034 | -12% | -$1.16M |
|
12
Bank of America
BAC
$376B
| $8.52M | 1.47% | 253,062 -62 | -0% | -$2.09K |
|
|
13
Gilead Sciences
GILD
$140B
| $7.83M | 1.35% | 96,633 -23,560 | -20% | -$1.91M |
|
|
14
Viatris
VTRS
$12.3B
| $7.7M | 1.33% | 711,349 -139,703 | -16% | -$1.51M |
|
|
15
Occidental Petroleum
OXY
$46.9B
| $7.26M | 1.25% | 121,536 -8,274 | -6% | -$494K |
|
16
US Bancorp
USB
$76B
| $7.25M | 1.25% | 167,431 -6,368 | -4% | -$276K |
|
17
Altria Group
MO
$113B
| $7.02M | 1.21% | 174,026 +12,802 | +8% | +$516K |
|
18
FedEx
FDX
$54.5B
| $6.41M | 1.11% | 25,320 -553 | -2% | -$140K |
|
|
19
Alibaba
BABA
$322B
| $5.89M | 1.02% | 76,022 -47,225 | -38% | -$3.66M |
|
20
Chevron
CVX
$324B
| $5.83M | 1.01% | 39,075 +1,814 | +5% | +$271K |
|
21
Kraft Heinz
KHC
$33.1B
| $5.63M | 0.97% | 152,370 +679 | +0.4% | +$25.1K |
|
|
22
Pfizer
PFE
$141B
| $5M | 0.86% | 173,535 +155,355 | +855% | +$4.47M |
|
23
Eli Lilly
LLY
$657B
| $4.94M | 0.85% | 8,475 -325 | -4% | -$189K |
|
24
Merck
MRK
$210B
| $4.89M | 0.85% | 44,860 -1,025 | -2% | -$112K |
|
25
IBM
IBM
$227B
| $4.79M | 0.83% | 29,267 -2,860 | -9% | -$468K |
|